No article notes available at this time.
• Provides prospective, long-term data supporting omission of radiation in select T1 STS patients who achieve clean (R0) surgical margins, rather than relying solely on retrospective series. • Offers benchmark local recurrence and survival figures (7.9%/10.6% at 5/10 years; 3.2% sarcoma-specific death) that residents can use to counsel patients considering surgery alone versus adjuvant radiation. • Reinforces that margin status—not just tumor grade or size within the T1 category—can be used as a practical criterion for selecting patients for a surgery-only approach.
No article notes available at this time.
• Provides prospective, long-term data supporting omission of radiation in select T1 STS patients who achieve clean (R0) surgical margins, rather than relying solely on retrospective series. • Offers benchmark local recurrence and survival figures (7.9%/10.6% at 5/10 years; 3.2% sarcoma-specific death) that residents can use to counsel patients considering surgery alone versus adjuvant radiation. • Reinforces that margin status—not just tumor grade or size within the T1 category—can be used as a practical criterion for selecting patients for a surgery-only approach.